Copyright ©The Author(s) 2018.
World J Gastroenterol. Oct 7, 2018; 24(37): 4230-4242
Published online Oct 7, 2018. doi: 10.3748/wjg.v24.i37.4230
Table 1 New prognostic biomarkers in patients undergoing liver transplantation for hepatocellular carcinoma
MalondialdehydeHigh circulating levelsLower survival[]
Total antioxidant capacityHigh circulating levelsLower survival[29]
Caspase-cleaved cytokeratin-18High circulating levelsLower survival[54]
Soluble CD40 ligandHigh circulating levelsLower survival[80]
Substance PHigh circulating levelsLower survival[107]
Neutrophil to lymphocyte ratioHigh circulating ratioLower survival[120]
Platelet to lymphocyte ratioHigh circulating ratioLower survival[120]
C-reactive proteinHigh circulating levelsLower survival[121,122]
Des-gamma-carboxy prothrombinHigh circulating levelsHigher recurrence[123-127]
Glypican-3High HCC expressionHigher recurrence[128]
H-TERT mRNAHigh peripheral blood expressionLower survival[130,131]
E-cadherinHigh HCC expressionHigher recurrence[142]
Beta-cateninHigh HCC expressionHigher recurrence[142]
Dickkopf-1High HCC expressionLower survival[154]
Vascular endothelial growth factorHigh circulating levelsLower survival[156]